Michael Graves - Net Worth and Insider Trading
Michael Graves Net Worth
The estimated net worth of Michael Graves is at least $4,550 dollars as of 2024-04-25. Michael Graves is the Director of Eagle Pharmaceuticals Inc and owns about 1,000 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $4,550. Details can be seen in Michael Graves's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Graves has not made any transactions after 2016-03-15 and currently still holds the listed stock(s).
Transaction Summary of Michael Graves
Michael Graves Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Graves owns 1 companies in total, including Eagle Pharmaceuticals Inc (EGRX) .
Click here to see the complete history of Michael Graves’s form 4 insider trades.
Insider Ownership Summary of Michael Graves
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2016-03-15 | director |
Michael Graves Latest Holdings Summary
Michael Graves currently owns a total of 1 stock. Michael Graves owns 1,000 shares of Eagle Pharmaceuticals Inc (EGRX) as of March 15, 2016, with a value of $4,550.
Latest Holdings of Michael Graves
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2016-03-15 | 1,000 | 4.55 | 4,550 |
Holding Weightings of Michael Graves
Michael Graves Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Graves has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the acquisition of 1,000 shares on March 15, 2016, which cost Michael Graves around $56,730.
Insider Trading History of Michael Graves
- 1
Michael Graves Trading Performance
GuruFocus tracks the stock performance after each of Michael Graves's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Graves is -16.7%. GuruFocus also compares Michael Graves's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Graves within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Graves's insider trading performs compared to the benchmark.
Performance of Michael Graves
Average Return
46.36%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -33.61 | -16.7 | 10.1 | 46.36 | -3.05 | -5.69 |
| Relative Return to S&P 500(%) | -36.82 | -19.46 | 3.59 | 28.04 | -19.79 | -17.56 |
Michael Graves Ownership Network
Ownership Network List of Michael Graves
Ownership Network Relation of Michael Graves
Michael Graves Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
Michael Graves is the director of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, Michael Graves made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 101,864 shares made by Scott Tarriff ,
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 101,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
Michael Graves Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Graves. You might contact Michael Graves via mailing address: C/o Par Pharmaceutical Companies, Inc., 300 Tice Boulevard, Woodcliff Lake Nj 07677.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
